Company / Current Assets per Share
Sarepta Therapeutics Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$26.19
FY2025
5-year range
$26.19 / $32.81
FY2021-FY2025
Trend
-20.1%
vs FY2024
Sector context
#20 of 210
Health Care
What the data says
Among 210 Health Care companies, Sarepta Therapeutics is in the top 10% for current assets per share. Current Assets per Share has fluctuated over the past 10 years, ranging from $8.18 in FY2016 to $33.05 in FY2020.
Based on SEC 10-K filings.
26.19 in FY2025 with a 5-year CAGR of -4.5%. Top quartile in the Health Care sector.
Declined from $29.33 to $26.19 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -3.7%
- 5-Year CAGR
- -4.5%
- 10-Year CAGR
- -
Sector benchmark
-84.7% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 20.1% year-over-year.
- Ranks #20 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.19 | -20.1% |
| FY2024 | $32.79 | +11.8% |
| FY2023 | $29.33 | -0.1% |
| FY2022 | $29.36 | -10.5% |
| FY2021 | $32.81 | -0.7% |
| FY2020 | $33.05 | +59.9% |
| FY2019 | $20.67 | -6.1% |
| FY2018 | $22.01 | -1.9% |
| FY2017 | $22.44 | +174.1% |
| FY2016 | $8.18 | +54.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026